Vaxcyte, Inc. PCVX Total Liabilities
Total Liabilities at other companies
Other financials
Where this comes from
Reported directly by Vaxcyte, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Liabilities.
The official record: Vaxcyte, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vaxcyte, Inc.'s total liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vaxcyte, Inc.'s total liabilities?
- Vaxcyte, Inc. (PCVX) reported total liabilities of $352.29M in Q1 2026.
- How has Vaxcyte, Inc.'s total liabilities changed year-over-year?
- Vaxcyte, Inc.'s total liabilities increased by 97.8% year-over-year, from $178.08M to $352.29M.
- What is the long-term trend for Vaxcyte, Inc.'s total liabilities?
- Over 5 years (2020 to 2025), Vaxcyte, Inc.'s total liabilities has grown at a 46.5% compound annual growth rate (CAGR), from $46.98M to $317.21M.
- What does total liabilities mean?
- The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.